For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230913:nRSM3556Ma&default-theme=true
RNS Number : 3556M Byotrol PLC 13 September 2023
Byotrol plc
("Byotrol" or the "Company")
Result of Annual General Meeting ("AGM")
Byotrol plc (AIM: BYOT), the developer of anti-microbial hygiene technologies,
announces that all resolutions proposed at the AGM held earlier today, as set
out in the Notice of Annual General Meeting, were duly passed.
The total proxy votes cast prior to the AGM were as follows:
Resolution In favour Discretion Against Withheld *
Votes % Votes % Votes % Votes
1 66,180,547 99.96% 1,500 0.01% 20,431 0.03% 1,339,665
2 64,703,257 95.88% 2,783,623 4.12% 55,263
3 64,681,263 95.84% 2,805,617 4.16% 55,263
4 66,189,047 98.11% 1,273,033 1.89% 80,063
5 65,854,428 97.57% 1,638,901 2.43% 48,814
6 64,561,174 95.66% 2,932,155 4.34% 48,814
7 66,077,089 97.90% 1,419,791 2.10% 45,263
*A vote withheld is not a vote in law and is therefore not counted towards the
proportion of votes "in favour" or "against" the resolutions.
Change of Name of Nominated Adviser and Broker
The Company also announces that its Nominated Adviser and Sole Broker has
changed its name to Cavendish Capital Markets Limited following completion of
its own corporate merger.
Enquiries:
Byotrol Plc
Trevor Francis - Chairman +44 (0)1925 742 000
Vivan Pinto - Chief Executive Officer
Chris Sedwell - Chief Financial Officer
Cavendish Capital Markets Limited (Nominated Adviser and Broker) +44 (0)20 7220 0500
Geoff Nash / George Dollemore - Corporate Finance
Nigel Birks / Harriet Ward - ECM
Flagstaff Strategic and Investor Communications +44 (0)20 7129 1474
Tim Thompson/Andrea Seymour/Fergus Mellon byotrol@flagstaffcomms.com (mailto:byotrol@flagstaffcomms.com)
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and
control company, operating globally in the Healthcare, Industrial, Food and
Consumer sectors, providing low toxicity products with a broad-based and
targeted efficacy across all microbial classes; bacteria, viruses (including
coronavirus), fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients within existing
products, where they can significantly improve their performance, especially
in personal hygiene, domestic and industrial disinfection, odour control, food
production and food management.
Byotrol develops and commercialises technologies that create easier, safer and
cleaner lives for everyone.
For more information, go to byotrol.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGFLFVSAIIVLIV